AU2001229461A1 - Method for inhibiting a tumor - Google Patents

Method for inhibiting a tumor

Info

Publication number
AU2001229461A1
AU2001229461A1 AU2001229461A AU2946101A AU2001229461A1 AU 2001229461 A1 AU2001229461 A1 AU 2001229461A1 AU 2001229461 A AU2001229461 A AU 2001229461A AU 2946101 A AU2946101 A AU 2946101A AU 2001229461 A1 AU2001229461 A1 AU 2001229461A1
Authority
AU
Australia
Prior art keywords
tumor
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229461A
Inventor
Leslie D. Bourquin
Soo-Young Kang
Muraleedharan G. Nair
Navindra P. Seeram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Michigan State University MSU
Original Assignee
Michigan State University MSU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michigan State University MSU filed Critical Michigan State University MSU
Publication of AU2001229461A1 publication Critical patent/AU2001229461A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2001229461A 2000-01-28 2001-01-12 Method for inhibiting a tumor Abandoned AU2001229461A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49407700A 2000-01-28 2000-01-28
US09494077 2000-01-28
PCT/US2001/001196 WO2001054516A1 (en) 2000-01-28 2001-01-12 Method for inhibiting a tumor

Publications (1)

Publication Number Publication Date
AU2001229461A1 true AU2001229461A1 (en) 2001-08-07

Family

ID=23962936

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229461A Abandoned AU2001229461A1 (en) 2000-01-28 2001-01-12 Method for inhibiting a tumor

Country Status (4)

Country Link
US (1) US6656914B2 (en)
AU (1) AU2001229461A1 (en)
CA (1) CA2398389C (en)
WO (1) WO2001054516A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003252766A (en) * 2002-02-28 2003-09-10 Sanei Gen Ffi Inc Antiobesity and/or antidiabetic agent containing cyanidin 3-glucoside as active component
US20050013880A1 (en) * 2003-03-06 2005-01-20 Magnuson Bernadene Ann Anthocyanin-rich compositions and methods for inhibiting cancer cell growth
US20060024392A1 (en) * 2004-04-20 2006-02-02 The University Of Maryland Compositions and methods for enhancing the effectiveness of a chemotherapeutic agent
US7737121B2 (en) * 2004-07-29 2010-06-15 Board Of Trustees Of Michigan State University Insulin secretion by anthocyanins and anthocyanidins
US8367126B2 (en) 2005-09-27 2013-02-05 University Of Kentucky Research Foundation Berry preparations and extracts
CA2622286A1 (en) * 2005-09-27 2007-04-05 University Of Kentucky Research Foundation Anti-inflammatory composition comprising berry extract
CA2661274A1 (en) * 2006-08-29 2008-03-06 University Of Kentucky Research Foundation Compositions and methods for oral cancer chemoprevention using berry preparations and extracts
KR100880876B1 (en) * 2007-04-11 2009-01-30 경상대학교산학협력단 Pharmaceutical composition for the prevention and treatment of the ischemia-reperfusion injury in the flaps or tissues containing anthocyanin extracted from the Black soybean seed coat
KR100832240B1 (en) * 2007-04-11 2008-05-28 경상대학교산학협력단 Pharmaceutical composition for wound healing containing anthocyanin extracted from the black soybean seed coat
US8642847B2 (en) * 2007-06-21 2014-02-04 Lee K. French Corn inbreds like FAR601 and hybrids thereof
CN102762573B (en) * 2009-07-24 2015-09-16 阿马曾提斯公司 For protecting the compound of brain health, composition and method in neurodegenerative disorders
KR101091025B1 (en) 2009-08-05 2011-12-09 고려대학교 산학협력단 Composition for curing NSAIDs-induced gastric antral ulceration comprising the extract of Rubus coreanus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL241315A (en) 1958-07-18
US5925620A (en) * 1990-08-20 1999-07-20 Ohlenschlaeger; Gerhard Therapeutically active mixture of glutathione and anthocyanin compounds
US5985636A (en) * 1997-02-12 1999-11-16 Board Of Trustees Operating Michigan State University Method and compositions for inhibiting oxidation

Also Published As

Publication number Publication date
US6656914B2 (en) 2003-12-02
CA2398389A1 (en) 2001-08-02
CA2398389C (en) 2008-04-15
US20010016573A1 (en) 2001-08-23
WO2001054516A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU2001259056A1 (en) Method for selectively inhibiting ghrelin action
AU2001290616A1 (en) A method for identifying polymorphisms
AU2002218140A1 (en) Beam-shaping method
AU2002220625A1 (en) Method for producing a strip-shaped object
AU2001234730A1 (en) Method for inhibiting complement activation
AU2002213972A1 (en) Method for producing polyisobutenylphenoles
AU2001229461A1 (en) Method for inhibiting a tumor
AU1070701A (en) A method for inhibiting hydrate formation
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001220281A1 (en) Rollerboard for road-skiing
AU3882400A (en) A method for protection against tumor metastasis formation
AU2001237530A1 (en) Method
AU2001270421A1 (en) Method for providing a demand for skill
AU2002224842A1 (en) Method for binding compound elements
AU2001241636A1 (en) Halotherapy method
AU2001224530A1 (en) Methods for protecting a surface
AU2001225621A1 (en) Method for producing nitrogenous-potash fertiliser
AU2001283792A1 (en) Method for automatically identifying a directed structure
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AUPQ680300A0 (en) A method
AU2002228911A1 (en) Methods for inhibiting pain
AUPQ856700A0 (en) Method for creating geometric figures
AU2001266471A1 (en) A method for interactive configuration
AU2562001A (en) Method for producing nitrogenous-potash fertiliser